George Sellers
Stock Analyst at Stephens & Co.
(1.04)
# 3,883
Out of 5,112 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $69.59 | -2.28% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $124.50 | +132.93% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $36.16 | +60.40% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $121.07 | +47.02% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $9.55 | +151.31% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $27.32 | +163.54% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.71 | +34.77% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $2.49 | +904.02% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $24.02 | +137.30% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $113.21 | -37.28% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $69.59
Upside: -2.28%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $124.50
Upside: +132.93%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $36.16
Upside: +60.40%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $121.07
Upside: +47.02%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.55
Upside: +151.31%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $27.32
Upside: +163.54%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.71
Upside: +34.77%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $2.49
Upside: +904.02%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $24.02
Upside: +137.30%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $113.21
Upside: -37.28%